OBJECTIVE: To determine the frequency of pancreatic @entity3 from @entity1358 in @entity1 studied with MDCT during 2007 and to describe the patterns of presentation on MDCT. MATERIAL AND METHODS: We retrospectively studied 133 @entity1 with @entity1358 who underwent MDCT between January and December 2007. Forty-nine @entity1 presented disseminated disease. We analyzed the frequency, location, and patterns of presentation of pancreatic @entity3 . RESULTS: Pancreatic involvement was identified in six @entity1 . Four @entity1 had isolated pancreatic nodules and two presented multiple nodules. A total of nine pancreatic lesions ranging between 8mm and 40 mm were detected. All nodules had increased uptake of contrast material in the arterial phase except for one in a @entity1 with multiple nodules, due to @entity39 . Two cases were associated with @entity384 . Histology was obtained in only one @entity1 . CONCLUSION: Pancreatic involvement of @entity1358 was detected in 4.5% of @entity1 , ranking fifth in frequency in @entity1 with disseminated disease. The arterial phase is necessary to detect pancreatic involvement of @entity1358 . The pattern of presentation is nearly constant, helping differentiate pancreatic @entity3 from primary @entity788 .

[MDCT patterns of presentation of pancreatic @entity3 from XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatic adenocarcinoma'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis'] @entity384 :: ('MESH:D002311', 'Disease') :: ['pancreatic duct dilation'] @entity1358 :: ('MESH:D002292', 'Disease') :: ['renal cell carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis', 'metastases']
@entity1358 :: (MESH:D002292,Disease) :: ['renal cell carcinoma']
